Apr 21, 2022 7:59am EDT Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
Apr 20, 2022 8:01am EDT Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study
Apr 19, 2022 7:22am EDT Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group
Apr 06, 2022 8:46am EDT Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label
Apr 04, 2022 9:11am EDT Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
Apr 01, 2022 2:17pm EDT Update: Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates
Apr 01, 2022 11:29am EDT Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates
